XXXX of the carotid arteries.

@entity1 @entity64 @entity932 @entity16 @entity4267 @entity731 @entity438
Fibromuscular disease of the carotid artery was identified in 30 @entity1 , which represented 3.2 percent of all @entity1 who had cerebral angiography at Brooke Army Medical Center in the 6 year period from 1978 to 1984. Focal neurologic events were the presenting symptoms in 63 percent of the @entity1 . The majority of the @entity1 were treated with antiplatelet therapy, and eight @entity1 had a total of 10 carotid artery dilatations. The only @entity1 with recurrent symptoms were those who received either no treatment or antiplatelet therapy. There were no recurrent symptoms in the operated @entity1 . This study suggests that surgical treatment for the symptomatic @entity1 may prevent recurrent symptoms with an acceptably low morbidity and mortality. There was, however, no indication that prophylactic dilation of the fibromuscular disease in the asymptomatic @entity1 was beneficial. @entity4267 of the carotid arteries is often associated with @entity438 , and surgical therapy rather than antiplatelet therapy may be advisable in @entity1 who have @entity438 . @entity1 with concomitant @entity731 of the carotid artery bifurcation should be treated like any @entity1 with @entity731 and an endarterectomy should be performed with carotid dilatation when indicated. Fibromuscular disease of the carotid artery is an infrequent angiographic finding that is associated with focal and @entity16 . Most @entity1 can be effectively treated with antiplatelet drugs with no recurrent symptoms, however, for persistent or progressive symptoms, some @entity1 will require surgical dilatation of the carotid artery. Fibromuscular disease of the carotid artery may lead to catastrophic symptoms of @entity64 or @entity932 if left undiagnosed or untreated.
